162 related articles for article (PubMed ID: 9838474)
1. Clinical trial of FK506 in heart transplant patients in Taiwan: report of 7 cases with immunosuppression switch from cyclosporine to FK506.
Ko WJ; Chou NK; Chen YS; Hsu RB; Wang SS; Chu SH
Transplant Proc; 1998 Nov; 30(7):3339-41. PubMed ID: 9838474
[No Abstract] [Full Text] [Related]
2. Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine.
Sgrosso JL; Ferrer J; Araujo G; Romeo L; Parisi C; Vázquez MC
Transplant Proc; 2002 Feb; 34(1):115-6. PubMed ID: 11959214
[No Abstract] [Full Text] [Related]
3. Primary immunosuppression with tacrolimus and mycophenolate mofetil versus cyclosporine and azathioprine in heart transplant recipients.
Teebken OE; Strüber M; Harringer W; Pichlmaier MA; Haverich A
Transplant Proc; 2002 Jun; 34(4):1265-8. PubMed ID: 12072335
[No Abstract] [Full Text] [Related]
4. Replacement of cyclosporine by tacrolimus for immunosuppression in heart transplant patients: safety and efficacy.
Crespo-Leiro MG; Paniagua MJ; Mosquera I; Tabuyo T; De la Fuente L; Bouzas B; Rodriguez JA; Hermida LF; Juffé A; Castro-Beiras A
Transplant Proc; 2002 Feb; 34(1):113-4. PubMed ID: 11959213
[No Abstract] [Full Text] [Related]
5. Rescue FK506 therapy for acute rejection and early chronic rejection after liver transplantation: report of 14 cases.
Taibi A; Adham M; Ducerf C; Chevallier M; Bizollon T; Delaroche E; Aljuaid N; Berthoux N; Baulieux J
Transplant Proc; 1998 Jun; 30(4):1411-2. PubMed ID: 9636571
[No Abstract] [Full Text] [Related]
6. Adult heart transplantation under tacrolimus (FK506) immunosuppression: histopathologic observations and comparison to a cyclosporine-based regimen with lympholytic (ATG) induction.
Tsamandas AC; Pham SM; Seaberg EC; Pappo O; Kormos RL; Kawai A; Griffith BP; Zeevi A; Duquesnoy R; Fung JJ; Starzl TE; Demetris AJ
J Heart Lung Transplant; 1997 Jul; 16(7):723-34. PubMed ID: 9257254
[TBL] [Abstract][Full Text] [Related]
7. Incidence of humoral rejection in heart transplant recipients treated with tacrolimus or cyclosporine A.
Behr TM; Richter K; Fischer P; Spes CH; Meiser B; Reichart B; Pongratz D; Feucht H; Theisen K; Angermann CE
Transplant Proc; 1998 Aug; 30(5):1920-1. PubMed ID: 9723333
[No Abstract] [Full Text] [Related]
8. FK506 for primary and rescue therapy following liver transplantation.
Platz KP; Mueller AR; Zytowski M; Lobeck H; Neuhaus P
Transplant Proc; 1998 Jun; 30(4):1409-10. PubMed ID: 9636570
[No Abstract] [Full Text] [Related]
9. Clinical outcomes associated with conversion to tacrolimus-based immunosuppression in pediatric cardiac transplantation.
Walker RE; McCrindle BW; Coles JG; West LJ
Transplant Proc; 1998 Jun; 30(4):1116-7. PubMed ID: 9636452
[No Abstract] [Full Text] [Related]
10. FK506 "rescue" therapy complicated by renal tubular acidosis in renal allograft recipients.
Goh BL; Tan SY
Transplant Proc; 1998 Nov; 30(7):3594-5. PubMed ID: 9838575
[No Abstract] [Full Text] [Related]
11. Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Ichikura H; Tanabe K; Tokumoto T; Shimuzu T; Ishikawa N; Harano M; Inui M; Manu M; Ito S; Shimmura H; Okuda H; Yagisawa T; Fuchinoue S; Toma H
Transplant Proc; 2000 Nov; 32(7):1733-5. PubMed ID: 11119911
[No Abstract] [Full Text] [Related]
12. Conversion to tacrolimus (FK506) from cyclosporine after orthotopic lung transplantation.
Lipson DA; Palevsky HI; Kotloff RM; Edelman J
Transplant Proc; 1998 Jun; 30(4):1505-7. PubMed ID: 9636612
[No Abstract] [Full Text] [Related]
13. Tacrolimus to rescue refractory hepatic allograft rejection: a collaborative study in Taiwan.
Hung CM; Jeng LB; Yeh CN; Hsieh CH; Lee WC; Chen MF
Transplant Proc; 1998 Nov; 30(7):3589. PubMed ID: 9838572
[No Abstract] [Full Text] [Related]
14. Benefits of mycophenolate mofetil in cardiac transplant recipients with cyclosporine-induced nephropathy.
Sánchez V; Delgado JF; Blasco T; Dalmau R; Morales JM; Escribano P; Tello R; Hernández J; Velázquez T; Sotelo T; Gómez-Sánchez MA; Sáenz de la Calzada C
Transplant Proc; 1999 Sep; 31(6):2515-6. PubMed ID: 10500695
[No Abstract] [Full Text] [Related]
15. Improved survival after lung transplantation in patients treated with tacrolimus/mycophenolate mofetil as compared with cyclosporine/azathioprine.
Izbicki G; Shitrit D; Aravot D; Sulkes J; Saute M; Sahar G; Kramer MR
Transplant Proc; 2002 Dec; 34(8):3258-9. PubMed ID: 12493439
[No Abstract] [Full Text] [Related]
16. Conversion to tacrolimus in case-problem kidney transplant recipients under cyclosporine-based immunosuppression.
Martins L; Henriques AC; Dias L; Sarmento AM; Pereira MC; Guimaräes S
Transplant Proc; 2000 Dec; 32(8):2636-8. PubMed ID: 11134735
[No Abstract] [Full Text] [Related]
17. Medium-term outcome of tacrolimus immunosuppression following rejection or graft dysfunction in heart transplant patients.
Marcus N; Khaghani A; Burke M; Yacoub M; Banner N
Transplant Proc; 1998 Jun; 30(4):1134-5. PubMed ID: 9636460
[No Abstract] [Full Text] [Related]
18. Immunosuppression switch in pediatric heart transplant recipients: cyclosporine to FK 506.
Swenson JM; Fricker FJ; Armitage JM
J Am Coll Cardiol; 1995 Apr; 25(5):1183-8. PubMed ID: 7534779
[TBL] [Abstract][Full Text] [Related]
19. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
20. A randomized comparison of an immunosuppressive strategy using tacrolimus and cyclosporine in black heart transplant recipients.
Mehra MR; Uber PA; Park MH; Prasad AK; Scott RL
Transplant Proc; 2001; 33(1-2):1606-7. PubMed ID: 11267438
[No Abstract] [Full Text] [Related]
[Next] [New Search]
